180 results
DEFA14A
IBRX
ImmunityBio Inc
29 Apr 24
Additional proxy soliciting materials
4:20pm
as ImmunityBio’s independent registered public accounting firm for the fiscal year ending December 31, 2024. For NOTE: In their discretion, the proxies
S-3ASR
EX-4.3
IBRX
ImmunityBio Inc
17 Apr 24
Automatic shelf registration
5:24pm
of independent certified public accountants or investment bank expressed in a written certification thereof delivered to the Trustee, are then in excess … , sufficient, in the opinion of a nationally recognized firm of independent public accountants or investment bank expressed in a written certification
S-3ASR
EX-23.1
IBRX
ImmunityBio Inc
17 Apr 24
Automatic shelf registration
5:24pm
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts
S-3ASR
tksllf 1hu3
17 Apr 24
Automatic shelf registration
5:24pm
424B5
mfte4m7h
24 Jul 23
Prospectus supplement for primary offering
5:12pm
8-K
EX-1.1
di2tkd8e t54
21 Jul 23
ImmunityBio Announces Execution of $40 Million Equity Financing with Institutional Investors
6:04am
8-K
EX-10.1
rlgl8vcu 8e1bj
21 Jul 23
ImmunityBio Announces Execution of $40 Million Equity Financing with Institutional Investors
6:04am
8-K
EX-4.1
jzazq7cu6e7dy
21 Jul 23
ImmunityBio Announces Execution of $40 Million Equity Financing with Institutional Investors
6:04am